" class="no-js "lang="en-US"> Fundraising Archives - Page 25 of 41 - Medtech Alert
Monday, October 20, 2025

Sort by:

Date

Top Post

Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience

Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]

Ori Biotech Raises Over $100 Million in Series B Funding to Launch Innovative Cell and Gene Therapy Manufacturing Platform

Ori Biotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, today announces […]

Verana Health Secures $150M Series E Funding Round

Verana Health, a digital health company that delivers quality drug lifecycle and medical practice insights […]

HeyRenee Raises Another $4.4M in Oversubscribed Seed II Funding Round Led by Quiet Capital

HeyRenee, the newest health-tech innovation from Dr. Renee Dua and Nick Desai, the founders of […]

Cheshire-based Life Sciences Startup Cryoniss Secures £500,000 Investment From NPIF Maven Equity Finance

NPIF Maven Equity Finance, managed by Maven Capital Partners (“Maven”) and part of the Northern […]

Digital Health Leader Verana Health Secures $150M Series E Funding Round

Verana Health, a digital health company that delivers quality drug lifecycle and medical practice insights […]

Significant Investment Accelerates Freenome's Multiomics Platform for the Early Detection of Cancer

Freenome, a privately held biotech company, announced today that Roche has made an investment of $290 […]

Future Fertility Raises Series A to Progress First-In-Class AI-Enabled Fertility Solutions to Improve IVF Outcomes

Future Fertility, a fertility technology company developing AI-enabled and non-invasive fertility solutions to optimize clinical […]

ViCentra Closes EUR 65M (USD 74M) Series C Funding to Expand Footprint of World’s Smallest Insulin Pump Across Europe

ViCentra, the company behind Kaleido, the world’s smallest and lightest wearable insulin pump (“patch pump”), announces […]

Bloom Science Raises USD $12 Million in Series A Financing

San Diego based biotech company Bloom Science announced today it successfully closed a USD $12 Million Series A […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more